We are live on ! Find out more
RBC

Romano Brothers & Co Portfolio holdings

AUM $994M
1-Year Est. Return 41.36%
This Fund
S&P 500
This Quarter Est. Return
+0.34%
1 Year Est. Return
+41.36%
3 Year Est. Return
+100.69%
5 Year Est. Return
10 Year Est. Return
AUM
$792M
AUM Growth
-$10.5M
Cap. Flow
-$2.57M
Cap. Flow %
-0.32%
Top 10 Hldgs %
25.53%
Holding
314
New
4
Increased
54
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.81M
2
PEP icon
PepsiCo
PEP
+$2.48M
3
LRCX icon
Lam Research
LRCX
+$2.14M
4
CON
Concentra Group Holdings
CON
+$1.27M
5
GPC icon
Genuine Parts
GPC
+$1.15M

Top Sells

Rank Stock Value
1
IP icon
International Paper
IP
+$2.28M
2
CVS icon
CVS Health
CVS
+$1.59M
3
SEM
Select Medical
SEM
+$1.26M
4
INTC icon
Intel
INTC
+$848K
5
SWK icon
Stanley Black & Decker
SWK
+$705K

Sector Composition

Rank Sector Weight
1 Technology 23.06%
2 Industrials 12.82%
3 Healthcare 11.96%
4 Financials 8.77%
5 Consumer Discretionary 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
201
Northern Trust
NTRS
$33.3B
$559K 0.07%
5,450
TSLX icon
202
Sixth Street Specialty
TSLX
$1.63B
$558K 0.07%
26,200
-500
-2% -$10.4K
PH icon
203
Parker-Hannifin
PH
$123B
$547K 0.07%
860
-26
-3% -$17.2K
O icon
204
Realty Income
O
$59.6B
$544K 0.07%
10,194
+200
+2% +$11.6K
NVO
205
Novo Nordisk
NVO
$208B
$544K 0.07%
6,328
+680
+12% +$73.5K
INTC icon
206
Intel
INTC
$455B
$540K 0.07%
26,935
-37,602
-58% -$848K
BX icon
207
Blackstone
BX
$102B
$535K 0.07%
3,104
-15
-0.5% -$2.61K
VWO icon
208
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$528K 0.07%
11,998
-2
-0% -$93
XYL icon
209
Xylem
XYL
$27.3B
$513K 0.06%
4,425
BAX icon
210
Baxter International
BAX
$13.5B
$503K 0.06%
17,241
-15,438
-47% -$520K
PFG icon
211
Principal Financial Group
PFG
$24.3B
$502K 0.06%
6,485
TMO icon
212
Thermo Fisher Scientific
TMO
$213B
$484K 0.06%
930
+15
+2% +$8.25K
DHR icon
213
Danaher
DHR
$137B
$483K 0.06%
2,106
IR icon
214
Ingersoll Rand
IR
$32.6B
$481K 0.06%
5,318
-350
-6% -$34.8K
VGK icon
215
Vanguard FTSE Europe ETF
VGK
$30.7B
$480K 0.06%
7,555
-100
-1% -$6.68K
XLP icon
216
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$474K 0.06%
6,025
GWW icon
217
W.W. Grainger
GWW
$65.3B
$464K 0.06%
440
-60
-12% -$67.6K
EW icon
218
Edwards Lifesciences
EW
$49.6B
$457K 0.06%
6,172
-50
-0.8% -$3.5K
XEL icon
219
Xcel Energy
XEL
$48.8B
$457K 0.06%
6,762
-100
-1% -$6.71K
SHEL icon
220
Shell
SHEL
$254B
$456K 0.06%
7,284
-250
-3% -$16.4K
IWF icon
221
iShares Russell 1000 Growth ETF
IWF
$121B
$451K 0.06%
4,492
NKE icon
222
Nike
NKE
$61.9B
$440K 0.06%
5,821
-1,993
-26% -$157K
SWKS icon
223
Skyworks Solutions
SWKS
$9.37B
$439K 0.06%
4,948
-300
-6% -$27.3K
MDLZ icon
224
Mondelez International
MDLZ
$79.5B
$439K 0.06%
7,345
PAYX icon
225
Paychex
PAYX
$41.6B
$438K 0.06%
3,125
-60
-2% -$8.52K

Similar funds

Romano Brothers & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Romano Brothers & Co held 314 positions worth $792M, down 1.3% from $803M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Romano Brothers & Co's Q4 2024 filing shows 4 new, 54 increased, 159 reduced and 12 closed positions. Its largest new stake was Lam Research: 28,185 shares worth $2.04M. The largest sale was International Paper, an estimated $2.28M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Romano Brothers & Co's largest Q4 2024 buy was Lam Research: 28,185 shares worth $2.04M.
  • Romano Brothers & Co added most to Becton Dickinson in Q4 2024, an estimated $2.81M increase.
  • Romano Brothers & Co's biggest Q4 2024 reduction was International Paper, cutting an estimated $2.28M.
  • Romano Brothers & Co fully exited DuPont de Nemours in Q4 2024, selling an estimated $307K.
  • Romano Brothers & Co's ten largest holdings make up 26% of its $792M portfolio in Q4 2024.
  • Romano Brothers & Co opened 4 new positions and closed 12 in Q4 2024.
  • Romano Brothers & Co's portfolio value fell 1.3% quarter-over-quarter to $792M.

Based on Romano Brothers & Co's 13F filing for Q4 2024, filed 16 Jan 2025.